Ozempic (semaglutide) is a prescription drug in a class of medications called GLP-1 agonists (a/k/a glucagon-like peptide-1 receptor agonists, GLP-1 receptor agonists GLP-1-RA, incretin mimetics, or GLP-1 analogs) that have been used to treat type 2 diabetes and obesity by lowering blood sugar, helping the pancreas produce more insulin, and slowing the rate that food passes through the body
Original Publication Date: January 23, 2024 Last Updated: May 16, 2024 These data come from Cosmos, a collaboration of 236 Epic health systems representing more than 227 million patient records from 1,301 hospitals and more than 28,600 clinics from all 50 states and Lebanon
Each manufacturer is responsible for adequately warning about their own products risks
The July 2025 change kept Wegovy (and Saxenda) on the standard formulary, with prior authorization under the same BMI and 6-month-program structure